Navigation Links
BioMarin to Present at the Barclays Global Healthcare Conference
Date:3/8/2011

NOVATO, Calif., March 8, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Barclays Global Healthcare Conference in Miami on Tuesday, March 15, 2011 at 4:15 p.m. ET.  

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical d
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin to Present at the Cowen Health Care Conference
2. BioMarin to Present at the Citi Global Healthcare Conference
3. BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
4. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
5. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
6. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
7. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
8. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
9. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
10. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
11. BioMarin Announces Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 2015 Cardinal Health today announced the completion ... distributor of generic pharmaceuticals, over-the-counter medications and related products ... owned by Court Square Capital Partners. The $1.115 billion ... new debt.  Headquartered in ... revenues of approximately $450 million in 2014. There are ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp (OTCQB: ... present live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be ... to ask the company questions in real-time - both ... "virtual trade booth." If attendees are not able to ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... Ga., June 14, 2011 Cardinal Health today opened ... further expanding its nationwide capability to manufacture molecular imaging ... treatment of cancer, neurological disorders and heart disease. ... Positron Emission Tomography (PET) molecular imaging agents, one of ...
... June 14, 2011 Orthopedics This Week announced today ... News to supply Orthopedics This Week, the #1 source ... terminal subscribers including some of the most prominent investors ... The Bloomberg network includes portfolio managers, central bankers, finance ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3Orthopedics This Week Now on Bloomberg 2
(Date:7/6/2015)... ... , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of ... CAGR of over 3.2 percent in the years to come to hit the USD ... by an anticipated launch of a number of promising pipeline candidates and an increase ...
(Date:7/6/2015)... Columbus, OH (PRWEB) , ... July 06, 2015 ... ... obtaining the proper reimbursement for radiology services and ADVOCATE is leading the transition. ... leveraging their coding expertise with their Top 10 Tips for ICD-10. The ten ...
(Date:7/6/2015)... Irvine, CA (PRWEB) , ... July 06, 2015 ... ... for disease prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care ... disease, cancer, stroke and other serious medical conditions. Screenings are affordable and accurate ...
(Date:7/6/2015)... ... ... Seedstock today announced Pierre Sleiman, founder and CEO of Go Green ... Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 San ... will explore solutions and methodologies that small farmers and entrepreneurs are developing to improve ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... Associates has once again teamed up with Family Emergency Shelter Coalition (FESCO) and ... toward self-sufficiency. FESCO was created especially to provide emergency services and support for ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3
... Institute (GTRI) have developed a sensor system that continuously ... Worn in the pockets of a vest, the new ... attacks. , We are investigating whether we can go ... going on environmentally when the attack started, said Charlene ...
... from UCLA and Northwestern University have developed a ... invisible to the immune system, a discovery that ... cancer and other diseases. , The study, published ... provides an example of the enormous potential and ...
... knows that overweight people have a higher risk of heart attacks, ... people who carry their extra weight around their waist giving ... highest risk of all. , But despite the impact on human ... fat also known as visceral fat -- have eluded scientists. ...
... of Genetic Medicine (IGM) at Johns Hopkins will join ... Project, an ambitious effort that will involve sequencing the ... create the most detailed and medically useful picture to ... considerable headway in creating a map of common DNA ...
... Avoids Deadly Clotting Problems of Drug-Eluting Stents, ... with a nanothin,surface application shows promise in opening ... of drug-eluting stents,according to a study being presented ... (ISET)., The stent coating is 25,000 times ...
... Berkeley The environmental damage caused by rich ... more than their combined foreign debt, according to ... of countries, ecological footprints. , The study, led ... Thara Srinivasan, assessed the impacts of agricultural intensification ...
Cached Medicine News:Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Scientists use nanomaterials to localize and control drug delivery 2Health News:Scientists use nanomaterials to localize and control drug delivery 3Health News:The missing link between belly fat and heart disease? 2Health News:The missing link between belly fat and heart disease? 3Health News:The missing link between belly fat and heart disease? 4Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 3Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 4Health News:Rich nations' environmental footprints tread heavily on poor countries 2Health News:Rich nations' environmental footprints tread heavily on poor countries 3Health News:Rich nations' environmental footprints tread heavily on poor countries 4
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: